Treatment of Pulmonary Benign Disease with Completely VATS Lobectomy

郭永庆,粱朝阳,刘德若,石彬,田燕雏,宋之乙,张海涛,陈京宇,王在永,鲍彤
DOI: https://doi.org/10.15932/j.0253-9713.2012.01.016
2012-01-01
Abstract:Objective To evaluate the feasibility,safety and efficacy of completely thoracoscopic lobectomy in the treatment of chronic infectious pulmonary diseases.Method Forty-seven patients with benign pulmonary diseases from February 2007 to June 2011 underwent complete video-assisted thoracoscopic lobectomy,including 18 bronchiectasis,6 pulmonary cyst,6 tuberculoma,10 inflammatory pseudo-tumor,3 pulmonary sequestration,2 pulmonary aspergillosis.Results cVATS lobectomy was successfully performed in 44 patients,including 5 right upper lobectomies,3 right middle lobectomies,2 right middle and upper lobctomies,1 right middle and lower lobectomy,10 right lower lobectomies,7 left upper lobectomies,13 1eft lower lobectomies,3 left lower lobctomies plus lingular segmental resection.Threecases changed to aVATS(6.83%) due to bleeding caused by severe adhesion of blood vessels.No mortality or severe complications occurred peri-operatively.The mean time of cVATS was 172 min(ranged from 86 to 269 min),the average volume of bleeding was 148 ml(range 100~1200 ml),the average volume of drainage was 781 ml(range 200~2200 ml) and the average duration of drainage was 4.25 days(range 3~18 days).The average postoperative hospital stay was 8.9 days(range 6~20 days).Conclusion Lobectomy through cVATS is a safe and effective procedure for patients with benign pulmonary diseases.
What problem does this paper attempt to address?